0001615774-18-000196.txt : 20180108
0001615774-18-000196.hdr.sgml : 20180108
20180108193450
ACCESSION NUMBER: 0001615774-18-000196
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180104
FILED AS OF DATE: 20180108
DATE AS OF CHANGE: 20180108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McGuire Jonathan Will
CENTRAL INDEX KEY: 0001345539
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36747
FILM NUMBER: 18517593
MAIL ADDRESS:
STREET 1: 96 TALAMINE COURT
CITY: COLORADO SPRINGS
STATE: CO
ZIP: 80907
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SECOND SIGHT MEDICAL PRODUCTS INC
CENTRAL INDEX KEY: 0001266806
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3
CITY: SYLMAR
STATE: CA
ZIP: 91342
BUSINESS PHONE: 818-833-5000
MAIL ADDRESS:
STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3
CITY: SYLMAR
STATE: CA
ZIP: 91342
4
1
s108662_form4.xml
4
X0306
4
2018-01-04
0
0001266806
SECOND SIGHT MEDICAL PRODUCTS INC
EYES
0001345539
McGuire Jonathan Will
12744 SAN FERNANDO ROAD
SUITE 400
SYLMAR
CA
91342
1
1
0
0
Chief Executive Officer
Common Stock
81339
D
Non-Qualified Stock Option (right to buy)
2.06
2018-01-04
4
A
0
450000
D
2019-01-04
2028-01-04
Common Stock
450000
450000
D
Warrant to Purchase Common Stock
1.47
2017-03-14
2022-03-14
Common Stock
6794
6794
D
Non-Qualified Stock Option (right to buy)
1.97
2018-01-03
2027-01-03
Common Stock
571330
571330
D
Non-Qualified Stock Option (right to buy)
4.1
2017-01-21
2026-01-21
Common Stock
21290
21290
D
Non-Qualified Stock Option (right to buy)
12.43
2016-08-17
2025-08-17
Common Stock
420000
420000
D
Restricted Stock Unit (RSU)
2016-08-17
2019-08-17
Common Stock
190000
83125
D
The shares subject to this option shall vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of January 4, 2018 (the "Vesting Commencement Date") and 6.25% of the total number of shares shall vest each quarterly anniversary of the Vesting Commencement Date thereafter, for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.
Options and RSUs vest over a 4 year term, with 25% vesting on the Date Exercisable as set forth in this Form 4 and thereafter vesting in 12 equal quarterly installments of 6.25%.
Not Applicable
/s/ Jonathan Will McGuire
2018-01-08